Chinabio Today -- As China takes a week off to celebrate the 60th anniversary of the People’s Republic, ChinaBio® Today covered three stories with longer-term impact during this past week’s coverage, particularly the re-emergence of life science IPOs, the now-enacted amendments to China’s patent law, and two new sources of life science investment capital.
